Rare diseases
Investigational molecules
Locations
705 conditions with trials, the busiest first
3 901 trials across Europe, recruiting first
Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors
FranceStudy of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Stage I Triple-Negative Breast Cancer
SpainStudy of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
BelgiumStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
BelgiumStudy of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy
FranceStudy of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis
FranceStudy on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers
BelgiumStudy of roginolisib, dostarlimab and docetaxel combination for patients with advanced non-small cell lung cancer who did not respond to previous immunotherapy and chemotherapy
BelgiumStudy on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients
BelgiumStudy on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma
AustriaStudy on Electrochemotherapy with Bleomycin for Patients with Recurrent Oral and Oropharyngeal Cancer
ItalyStudy on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab
BulgariaThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
